The Discounted Cash Flow (DCF) valuation of Resmed Inc (RMD) is 289.73 USD. With the latest stock price at 252.87 USD, the upside of Resmed Inc based on DCF is 14.6%.
Based on the latest price of 252.87 USD and our DCF valuation, Resmed Inc (RMD) is a buy. buying Resmed stocks now will result in a potential gain of 14.6%.
| Range | Selected | |
| WACC / Discount Rate | 7.0% - 9.4% | 8.2% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 204.54 - 525.98 | 289.73 |
| Upside | -19.1% - 108.0% | 14.6% |